Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival

MLA

Hélène Salaun, et al. Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival. June 2020. EBSCOhost, https://doi.org/10.17863/cam.53658.

APA

Hélène Salaun, Charlotte Proudhon, Chantal Bourrier, Ellen Heitzer, Laura Xuereb, Michael R. Speicher, Nolwen Guigal-Stephan, Jean-Yves Pierga, Brian Paul Lockhart, & Jelena Belic. (2020). Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival. https://doi.org/10.17863/cam.53658

Chicago

Hélène Salaun, Charlotte Proudhon, Chantal Bourrier, Ellen Heitzer, Laura Xuereb, Michael R. Speicher, Nolwen Guigal-Stephan, Jean-Yves Pierga, Brian Paul Lockhart, and Jelena Belic. 2020. “Shallow Whole-Genome Sequencing from Plasma Identifies FGFR1 Amplified Breast Cancers and Predicts Overall Survival,” June. doi:10.17863/cam.53658.